These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 6766174)
1. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. Merz DC; Scheid A; Choppin PW J Exp Med; 1980 Feb; 151(2):275-88. PubMed ID: 6766174 [TBL] [Abstract][Full Text] [Related]
2. Functions of surface glycoproteins of myxoviruses and paramyxoviruses and their inhibition. Choppin PW; Richardson CD; Merz DC; Scheid A Ciba Found Symp; 1981; 80():252-69. PubMed ID: 6911076 [TBL] [Abstract][Full Text] [Related]
3. Recent developments with live-attenuated recombinant paramyxovirus vaccines. Le Bayon JC; Lina B; Rosa-Calatrava M; Boivin G Rev Med Virol; 2013 Jan; 23(1):15-34. PubMed ID: 22570186 [TBL] [Abstract][Full Text] [Related]
4. The functions and inhibition of the membrane glycoproteins of paramyxoviruses and myxoviruses and the role of the measles virus M protein in subacute sclerosing panencephalitis. Choppin PW; Richardson CD; Merz DC; Hall WW; Scheid A J Infect Dis; 1981 Mar; 143(3):352-63. PubMed ID: 7229437 [TBL] [Abstract][Full Text] [Related]
5. Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Merz DC; Wolinsky JS Virology; 1983 Dec; 131(2):328-40. PubMed ID: 6362184 [TBL] [Abstract][Full Text] [Related]
6. Role of paramyxovirus glycoproteins in the interactions between viral and cell membranes. Scheid A; Hsu M; Choppin PW Soc Gen Physiol Ser; 1980; 34():119-30. PubMed ID: 7384831 [TBL] [Abstract][Full Text] [Related]
7. Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins. Stone JA; Vemulapati BM; Bradel-Tretheway B; Aguilar HC J Virol; 2016 Dec; 90(23):10762-10773. PubMed ID: 27654290 [TBL] [Abstract][Full Text] [Related]
8. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Paterson RG; Russell CJ; Lamb RA Virology; 2000 Apr; 270(1):17-30. PubMed ID: 10772976 [TBL] [Abstract][Full Text] [Related]
9. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody. Tsurudome M; Yamada A; Hishiyama M; Ito Y J Gen Virol; 1986 Oct; 67 ( Pt 10)():2259-65. PubMed ID: 3760826 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. Schmitt AP; He B; Lamb RA J Virol; 1999 Oct; 73(10):8703-12. PubMed ID: 10482624 [TBL] [Abstract][Full Text] [Related]
12. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3. Schmidt AC; McAuliffe JM; Murphy BR; Collins PL J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329 [TBL] [Abstract][Full Text] [Related]
13. Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3. Homa FL; Brideau RJ; Lehman DJ; Thomsen DR; Olmsted RA; Wathen MW J Gen Virol; 1993 Sep; 74 ( Pt 9)():1995-9. PubMed ID: 8397289 [TBL] [Abstract][Full Text] [Related]
14. Fusion properties of cells constitutively expressing human parainfluenza virus type 4A haemagglutinin-neuraminidase and fusion glycoproteins. Nishio M; Tsurudome M; Komada H; Kawano M; Tabata N; Matsumura H; Ikemura N; Watanabe N; Ito Y J Gen Virol; 1994 Dec; 75 ( Pt 12)():3517-23. PubMed ID: 7996143 [TBL] [Abstract][Full Text] [Related]
15. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3. Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317 [TBL] [Abstract][Full Text] [Related]
16. Paramyxovirus-induced syncytium cell formation is suppressed by a dominant negative fusion regulatory protein-1 (FRP-1)/CD98 mutated construct: an important role of FRP-1 in virus-induced cell fusion. Okamoto K; Ohgimoto S; Nishio M; Tsurudome M; Kawano M; Komada H; Ito M; Sakakura Y; Ito Y J Gen Virol; 1997 Apr; 78 ( Pt 4)():775-83. PubMed ID: 9129649 [TBL] [Abstract][Full Text] [Related]
17. Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. Young DF; Randall RE; Hoyle JA; Souberbielle BE J Virol; 1990 Nov; 64(11):5403-11. PubMed ID: 1976819 [TBL] [Abstract][Full Text] [Related]
18. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine. Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633 [TBL] [Abstract][Full Text] [Related]
19. Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus. Umino Y; Kohama T; Kohase M; Sugiura A; Klenk HD; Rott R Arch Virol; 1984; 81(1-2):53-65. PubMed ID: 6743025 [TBL] [Abstract][Full Text] [Related]